CNO Financial Group, Inc. (CNO) · Oct 29, 2026 · Earnings
Beat — Operating EPS $1.90 vs ~$1.10 consensus; $1.42 excluding significant items
CNO earnings beat Q3 expectations and raised full-year operating EPS guidance, with underlying insurance profits improving despite a large actuarial tailwind.
CNO is a middle-income-focused insurer selling life, health and annuity products through Consumer and Worksite distribution, currently trying to convert several quarters of sales momentum into more durable profitability. Its prior-quarter update highlighted 16 consecutive quarters of insurance-sales growth and had already lifted 2026 operating EPS guidance, so the setup was constructive rather than distressed.
The quarter beat the published bar by a wide margin. Net operating EPS was $1.90 versus roughly $1.10 consensus, while total revenue was $1.086 billion versus roughly $1.01 billion expected. That is a clear earnings beat, although revenue still fell 8.6% year over year because investment losses and lower fee income offset higher insurance policy income. The filing states: “Net income was $161 million, or $1.71 per diluted share, and net operating income(1) was $179 million, or $1.90 per diluted share.”
| 3Q26 | 3Q25 | Consensus | |
|---|---|---|---|
| Total revenues (Income Statement) | $1,086.0M (-8.6%) | $1,188.7M | ~$1,010M |
| Net income per diluted share (Income Statement) | $1.71 (+612.5%) | $0.24 | ~$1.10 |
| Net operating income per diluted share (Financial Highlights) | $1.90 (+47.3%) | $1.29 | — |
| Net operating income per diluted share, excluding significant items (Significant Items) | $1.42 (+47.9%) | $0.96 | — |
| Operating ROE, excluding significant items (Ratios) | 14.1% | 11.2% | — |
The beat was not only an actuarial artifact, but the headline overstates the underlying acceleration. CNO received a $44.9 million, or $0.48 per share, favorable impact from its annual actuarial review; stripping that out still leaves $1.42 of operating EPS, comfortably above the published expectation. Insurance product income rose 15% to $172.0 million, with annuity and life margins improving, while health margin declined from the year-ago quarter. The filing says: “Significant items related to the comprehensive annual actuarial review had a $44.9 million net favorable impact on both net income and net operating income.”
Management raised the full-year operating EPS outlook again, reinforcing the profitability story. The filing gives no revised numerical range in the provided text, so the size of the increase cannot be assessed precisely; qualitatively, this is more than a routine reaffirmation and follows the guidance increase disclosed after the second quarter. The company states: “Based on these results, we are raising our full-year operating earnings per share guidance.” 〔0〕
Capital deployment and reinsurance remain supportive, but secondary to the earnings signal. CNO repurchased $60.0 million of stock during the quarter and, on October 1, completed a third Bermuda-affiliate reinsurance transaction covering approximately $270 million of Colonial Penn graded-benefit life reserves. Those actions fit the company’s effort to optimize capital and improve returns, but they do not change the central Q3 read: underlying operating performance cleared expectations even after removing the actuarial benefit.
Bottom line: This was a genuine earnings beat with another guidance increase, not merely a favorable accounting swing. The actuarial gain amplified the headline, but the underlying $1.42 operating EPS still points to better business performance than the market had expected.
Q3 earnings call, October 30, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!